The dysregulation of FOXO, MAPK, and MTOR signaling pathways was reported to play important roles in glucose metabolism leading to insulin-resistance-related metabolic disorders found in cancer [30,31,32], but their roles in PPCM and DCM are not well defined. This evidence concerns the gene MTOR and Insulin resistance.